Aversion therapy, a punishment-based behavioral technique that once targeted substance use disorders and sexual orientation, was largely abandoned after decades of poor clinical outcomes, ethical violations, and legal bans, replaced by evidence-based approaches like cognitive behavioral therapy and motivational interviewing that produce lasting change without deliberate harm.
For decades, deliberately causing pain was considered legitimate medical treatment. Aversion therapy was practiced in hospitals, endorsed by clinicians, and applied to everything from alcoholism to sexual orientation, until the evidence, the ethics, and the people it harmed made its continued use impossible to defend.
What is aversion therapy?
Aversion therapy is a behavioral treatment technique that pairs an unwanted behavior with an unpleasant stimulus, with the goal of creating a conditioned aversion response. The idea is straightforward: if a behavior becomes strongly associated with something uncomfortable, a person will learn to avoid it. Once considered a legitimate clinical tool, aversion therapy was applied to a range of conditions before serious ethical and efficacy concerns reshaped the field.
The technique is grounded in classical conditioning, the learning process most famously demonstrated by Ivan Pavlov. In a clinical aversion therapy context, the unwanted behavior acts as the conditioned stimulus, meaning the thing the treatment targets. A noxious stimulus, such as an electric shock or a drug that causes nausea, serves as the unconditioned stimulus, meaning the thing that naturally produces a negative response. Through repeated pairing, the person develops a conditioned avoidance response, associating the behavior itself with discomfort. Rooted in the broader Pavlovian conditioning framework, aversion responses are essentially the inverse of safety learning: rather than learning that something signals relief, the person learns that a behavior signals distress.
It is worth distinguishing aversion therapy from informal punishment. Aversion therapy is a structured clinical protocol, designed and administered within a therapeutic setting, not simply a consequence applied after the fact.
The conditions historically targeted by aversion therapy included alcoholism, substance use disorders, smoking, nail biting, and sexual behaviors that mid-20th century clinicians labeled deviant, most notably same-sex attraction. This range reflects the behaviorist paradigm that dominated psychology at the time: the view that all behavior is learned through conditioning and can, in theory, be unlearned the same way. That assumption, and its consequences, is where the story gets complicated.
How aversion therapy works
Aversion therapy is not a single procedure. It encompasses several distinct techniques, each using a different type of aversive stimulus to suppress unwanted behavior. Understanding what practitioners actually did in a session makes the ethical debates that followed much easier to grasp.
Chemical aversion
Chemical aversion was most commonly applied to alcohol use, a treatment still studied in the context of substance use disorders today. A clinician would administer an emetic drug, typically emetine or apomorphine, timed so that severe nausea and vomiting would peak at the exact moment the person tasted and smelled alcohol. The goal was to forge a conditioned association between alcohol’s sensory cues and physical illness. Research into the neurobiological mechanism of chemical aversion therapy suggests this pairing can reduce craving by disrupting the reward signals alcohol normally triggers in the brain. Pharmacological agents like disulfiram, sold under the brand name Antabuse, work on a related but distinct principle: the drug blocks alcohol metabolism and causes a deeply unpleasant physical reaction if the person drinks, though this differs from the classical conditioning protocol used in formal aversion sessions.
Electrical aversion
Electrical aversion replaced chemical methods in many clinical settings, largely because the timing of the stimulus was easier to control. A mild to moderate electric shock was delivered to the fingers or forearm at the precise moment a person engaged in, or viewed imagery related to, the target behavior. This technique was applied to a wide range of behaviors, including alcohol use, smoking, and others now recognized as requiring far more nuanced, affirming care. The dose-response problem was significant here: the shock had to be strong enough to override the reinforcing pull of the behavior, which placed clinicians in the uncomfortable position of calibrating discomfort as a therapeutic tool.
Covert sensitization and self-administered techniques
Covert sensitization offered a version of aversion therapy with no physical stimulus at all. A therapist would guide the client through detailed mental imagery, pairing vivid scenes of the unwanted behavior with nauseating or frightening imagined consequences. Because everything happened in the mind, it was considered more ethical and easier to administer. Self-administered techniques, such as snapping a rubber band against the wrist when an unwanted urge arose, grew out of this imaginal tradition and persisted in popular self-help culture. Despite their staying power, these rubber-band methods lack meaningful clinical evidence as standalone interventions and are not considered a legitimate therapeutic protocol today.
History of aversion therapy: a decade-by-decade timeline
Aversion therapy did not appear overnight. It evolved through decades of clinical experimentation, cultural controversy, and legal reckoning. The timeline below traces its rise and gradual dismantling, from a Seattle sanitarium in the 1930s to courtroom battles in the 2020s.
1930s: The Shadel Sanitarium in Seattle (now Schick Shadel Hospital) becomes the first institution to apply chemical aversion treatment systematically for alcoholism. Clinicians administer emetine, a drug that induces nausea and vomiting, pairing it with alcohol to build an aversive association. Early clinical records from Shadel Sanatorium document this as the foundational model for what would follow.
1950s–1960s: Electrical aversion therapy expands beyond substance use and is applied to homosexuality and behaviors classified as paraphilias. Institutions like Atascadero State Hospital conduct involuntary aversion protocols on incarcerated patients, often without meaningful consent. By 1962, the first systematic published studies on electrical aversion for homosexuality appear in clinical literature, lending a veneer of scientific legitimacy to deeply harmful practices.
1971: Stanley Kubrick’s A Clockwork Orange depicts a fictional aversion conditioning program in visceral detail. The film reaches mass audiences and generates widespread public revulsion, putting the ethics of behavioral control into mainstream conversation for the first time.
1972: The Wyatt v. Stickney ruling establishes that institutionalized patients have a constitutional right to treatment and protection from experimental procedures. This legal precedent directly challenges the unchecked use of aversive protocols in psychiatric facilities.
1973: The American Psychiatric Association removes homosexuality from the Diagnostic and Statistical Manual of Mental Disorders (DSM-II). With no clinical diagnosis to treat, the primary justification for aversion therapy targeting sexual orientation collapses.
1990s: Deinstitutionalization reshapes mental health care across the United States. As patients move out of large institutions, cognitive-behavioral therapies rise as the dominant evidence-based approach, further marginalizing aversive methods.
2009: An APA Task Force on Appropriate Therapeutic Responses to Sexual Orientation concludes formally that sexual orientation change efforts lack evidence of effectiveness and cause measurable psychological harm.
2012: California becomes the first U.S. state to ban conversion therapy for minors, setting a legislative template that dozens of states would follow in subsequent years.
2020: The FDA issues a final rule banning electrical stimulation devices used for aversive conditioning, specifically targeting the Judge Rotenberg Center’s use of the Graduated Electronic Decelerator (GED) on disabled individuals.
2021: The D.C. Circuit Court overturns the FDA’s GED ban on jurisdictional grounds. Legal challenges continue, leaving the practice in a contested gray zone.
2022: Canada enacts a federal criminal ban on conversion therapy, making it one of the strongest national-level prohibitions in the world.
This timeline reflects something important: aversion therapy did not fade because of a single discovery. It faded because of accumulating legal, ethical, and scientific pressure from many directions at once.
The conversion therapy connection: how LGBTQ+ harm made aversion therapy a pariah
No chapter in aversion therapy’s history is more damaging, or more morally urgent, than its use against LGBTQ+ individuals. From the 1950s through the 1970s, electroshock and chemical aversion techniques were routinely applied in attempts to change sexual orientation. Patients were often not there by choice. Institutional settings, family pressure, and legal coercion placed many people in rooms where clinicians administered pain as a supposed cure for who they were.
The case of Alan Turing stands as one of history’s starkest examples of this intersection between state power and medical authority. In 1952, the British mathematician and World War II code-breaker was convicted of “gross indecency” for a consensual same-sex relationship. His sentence: chemical castration through estrogen injections, administered as a condition of avoiding prison. He died two years later. His case did not represent an extreme outlier. It represented a system.
In the United States, abuses at institutions like Atascadero State Hospital in California brought the cruelty of these methods into sharp relief. Incarcerated patients, including gay men, were subjected to succinylcholine, a paralytic drug that induces temporary respiratory arrest, meaning patients experienced the sensation of suffocation while remaining conscious. This was paired with homosexual imagery as the intended aversive stimulus. As research on the historical psychiatric pathologisation of LGBTQ+ individuals documents, these coercive treatments were applied unevenly, with gender, class, and race shaping who faced the most extreme interventions.
The professional reckoning began in 1973, when the American Psychiatric Association declassified homosexuality as a mental disorder. That decision removed the diagnostic foundation on which conversion-oriented aversion therapy had rested. Then, in 2009, an APA Task Force reviewed decades of evidence and formally concluded that sexual orientation change efforts are both ineffective and harmful. The documented psychological consequences, including depression, anxiety, and traumatic stress responses, are now well established in the clinical literature.
Survivor testimony proved decisive in shifting both public opinion and professional standards. Advocacy organizations amplified those voices, and the legislative response followed. More than 20 U.S. states have now banned conversion therapy for minors, Canada enacted a federal ban in 2022, and similar legislative efforts continue globally. Aversion therapy did not quietly retire from this domain. It was named, condemned, and legislated against, because the people it harmed refused to let it disappear in silence.
The five forces that ended aversion therapy
Aversion therapy was pushed out by a convergence of pressures that built over decades, each weakening the technique’s foothold until the combined weight made its continued use professionally, legally, and ethically untenable. Five distinct forces drove this decline.
Clinical evidence failures
The most fundamental problem was that aversion therapy simply did not work well enough to justify its risks. Meta-analyses and controlled studies consistently showed poor long-term outcomes across the conditions it targeted. Relapse rates for alcohol aversion therapy were high, with many patients returning to drinking within months of treatment. No randomized controlled trials demonstrated that aversion therapy produced sustained superiority over placebo or active comparators for most conditions. When a treatment causes real suffering and still fails to outperform alternatives, the clinical case for it collapses.
The informed consent revolution
Through the latter half of the twentieth century, medicine shifted away from paternalistic authority toward patient autonomy. This shift was devastating for a technique that frequently relied on coercion: court-ordered treatment, institutional mandates, or participation under social and legal duress. Professional ethics codes formalized this change. The APA’s Ethical Principles, particularly the “Avoiding Harm” standard, created binding professional liability for administering techniques that cause distress without clear patient consent and benefit. The ACA Code of Ethics similarly codified client autonomy and the prohibition of coercive or value-imposing treatment. Aversion therapy, as commonly practiced, could not clear this bar.
Legal and regulatory action
Legal risk compounded ethical pressure. The landmark Wyatt v. Stickney ruling in 1972 established that institutionalized patients had constitutional rights to humane treatment, directly challenging the use of aversive procedures in psychiatric facilities. Decades later, the FDA banned the graduated electronic device used at one facility in 2020, marking the first time the agency prohibited a medical device specifically on the grounds of psychological harm. Conversion therapy bans enacted across dozens of states added further legal exposure. Malpractice liability made aversion therapy a professional risk that most practitioners and institutions were no longer willing to accept.